← Back to All Technologies

Hugh Sweeney

H. Lee Sweeney, Ph.D., is a Thomas H. Maren M.D. Eminent Scholar Chair in Pharmacology and Therapeutics at the University of Florida. He received his undergraduate degree in biochemistry from Massachusetts Institute of Technology and his Ph.D. in physiology and biophysics from Harvard. Dr. Sweeney’s basic research interests are focused on molecular motors of the myosin superfamily and small molecule therapy for the development of muscle disease. Dr. Sweeney is well known in the press for his gene-therapy approaches to permanently block the loss of age-related muscle size and strength in mice. In 2004, this work led Dr. Sweeney to being named one of the “Best and Brightest” in America by Esquire Magazine. 

Technologies
Variant AAV Particles for Improved Gene Therapy
Gene Therapy to Counter Obesity in People and Companion Animals
Tissue-Specific Chimeric Constructs for Treating Duchenne Muscular Dystrophy

Categories